CE vs CORT · rev $10.28B vs P/E 199, rev $675.0M
Celanese Corporation (CE) versus Corcept Therapeutics Incorporated (CORT) — a side-by-side from cached financials, not a winner call.
Celanese Corporation (CE) is a chemicals company listed on US.
Corcept Therapeutics Incorporated (CORT) is a biotechnology company listed on US.
Latest reported CE revenue for 2024-12-31 was $10.28B. Net income was -$1.51B. Revenue was down 6.0% from 2023-12-31 to 2024-12-31. CE currently screens at market cap $5.92B.
Latest reported CORT revenue for 2024-12-31 was $675.0M. Net income was $141.2M. Revenue was up 39.9% from 2023-12-31 to 2024-12-31. CORT currently screens at market cap $7.46B and trailing P/E 198.5.
CE currently screens at market cap $5.92B. CORT currently screens at market cap $7.46B and trailing P/E 198.5.
Not investment advice. Open the CE and CORT stock pages for the full models.
Not investment advice.